Literature DB >> 7925617

Molecular modeling of adenosine receptors. The ligand binding site on the rat adenosine A2A receptor.

A P IJzerman1, E M van der Wenden, P J van Galen, K A Jacobson.   

Abstract

The amino acid sequence of the rat adenosine A2A receptor and the atomic coordinates of bacteriorhodopsin were combined to generate a three-dimensional model for the adenosine A2A receptor. This model consists of seven amphipathic alpha-helices, forming a pore that is rather hydrophilic compared to the hydrophobic outside of the protein. Subsequently, a highly potent and selective ligand for this receptor, 2-(cyclohexylmethylidinehydrazino)adenosine (SHA 174), was docked into this cavity. A binding site is proposed that takes into account the conformational characteristics of the ligand. Moreover, it involves two histidine residues that were shown to be important for ligand coordination from chemical modification studies. Subsequently, the deduced binding site was used to model other potent ligands, including 8-(3-chlorostyryl)caffeine, a new A2-selective antagonist, that could all be accommodated consistent with earlier biochemical and pharmacological findings. Finally, some thoughts on how adenosine receptor activation might proceed are put forward, based on structural analogies with the enzyme family of serine proteases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925617      PMCID: PMC6939755          DOI: 10.1016/0922-4106(94)90124-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  38 in total

1.  A model of the adrenergic beta-2 receptor and binding sites for agonist and antagonist.

Authors:  X Q Lewell
Journal:  Drug Des Discov       Date:  1992

2.  Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

Authors:  K A Jacobson; G L Stiles; X D Ji
Journal:  Mol Pharmacol       Date:  1992-07       Impact factor: 4.436

Review 3.  Rhodopsin, photoreceptor of the rod cell. An emerging pattern for structure and function.

Authors:  H G Khorana
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

4.  Another catalytic triad?

Authors:  D W Christianson; R S Alexander
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

5.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  2-aralkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.

Authors:  M Ueeda; R D Thompson; L H Arroyo; R A Olsson
Journal:  J Med Chem       Date:  1991-04       Impact factor: 7.446

7.  Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.

Authors:  K A Jacobson; C Gallo-Rodriguez; N Melman; B Fischer; M Maillard; A van Bergen; P J van Galen; Y Karton
Journal:  J Med Chem       Date:  1993-05-14       Impact factor: 7.446

8.  Binding-site modeling of the muscarinic m1 receptor: a combination of homology-based and indirect approaches.

Authors:  G Nordvall; U Hacksell
Journal:  J Med Chem       Date:  1993-04-16       Impact factor: 7.446

9.  2',3'-Dideoxy-N6-cyclohexyladenosine: an adenosine derivative with antagonist properties at adenosine receptors.

Authors:  M J Lohse; K N Klotz; E Diekmann; K Friedrich; U Schwabe
Journal:  Eur J Pharmacol       Date:  1988-10-26       Impact factor: 4.432

10.  The probable arrangement of the helices in G protein-coupled receptors.

Authors:  J M Baldwin
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

View more
  10 in total

1.  Molecular modeling of the human A2a adenosine receptor.

Authors:  A A Ivanov; I I Baskin; V A Palyulin; N S Zefirov
Journal:  Dokl Biochem Biophys       Date:  2003 Mar-Apr       Impact factor: 0.788

2.  Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.

Authors:  Q Jiang; B X Lee; M Glashofer; A M van Rhee; K A Jacobson
Journal:  J Med Chem       Date:  1997-08-01       Impact factor: 7.446

3.  Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.

Authors:  Q Jiang; A M Van Rhee; J Kim; S Yehle; J Wess; K A Jacobson
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

4.  Modelling the P2Y purinoceptor using rhodopsin as template.

Authors:  A M Van Rhee; B Fischer; P J Van Galen; K A Jacobson
Journal:  Drug Des Discov       Date:  1995-11

5.  Site-directed mutagenesis of the human adenosine A2A receptor. Critical involvement of Glu13 in agonist recognition.

Authors:  A P IJzerman; J K Von Frijtag Drabbe Künzel; J Kim; Q Jiang; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1996-08-29       Impact factor: 4.432

6.  A binding site model and structure-activity relationships for the rat A3 adenosine receptor.

Authors:  P J van Galen; A H van Bergen; C Gallo-Rodriguez; N Melman; M E Olah; A P IJzerman; G L Stiles; K A Jacobson
Journal:  Mol Pharmacol       Date:  1994-06       Impact factor: 4.436

7.  Site-directed mutagenesis studies of human A(2A) adenosine receptors: involvement of glu(13) and his(278) in ligand binding and sodium modulation.

Authors:  Z G Gao; Q Jiang; K A Jacobson; A P Ijzerman
Journal:  Biochem Pharmacol       Date:  2000-09-01       Impact factor: 5.858

8.  Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.

Authors:  J Kim; Q Jiang; M Glashofer; S Yehle; J Wess; K A Jacobson
Journal:  Mol Pharmacol       Date:  1996-04       Impact factor: 4.436

9.  Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor.

Authors:  J Kim; J Wess; A M van Rhee; T Schöneberg; K A Jacobson
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

Review 10.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.